Cholestatic Liver Injury: Care of Patients With Primary Biliary Cholangitis or Primary Sclerosing Cholangitis

被引:6
作者
Larson, Laurie [1 ]
James, Michelle [2 ]
Gossard, Andrea [3 ]
机构
[1] Univ Minnesota, Hepatol, 406 Harvard St SE,MMC 36, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Transplant Serv, Minneapolis, MN USA
[3] Mayo Clin, Gastroenterol & Hepatol, Rochester, MN USA
关键词
Primary biliary cholangitis; primary sclerosing cholangitis; liver transplant; cholangiocarcinoma;
D O I
10.4037/aacnacc2016202
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
The most common causes of chronic cholestatic liver disease are primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). Both disease processes are characterized by a destruction of intrahepatic and/or extrahepatic biliary ducts. The etiology is not entirely clear; however, there is an underlying autoimmune component contributing to both disease processes. Although PBC and PSC are often diagnosed and managed in the outpatient setting, in some instances, a patient may have jaundice, fatigue, and pruritus requiring evaluation and determination of the cholestatic cause. Patients with PSC should be monitored for evidence of cholangiocarcinoma, colon cancer, and gallbladder polyps as they are at an increased risk of malignant neoplasms. Liver transplant has the potential for improving quality of life, although disease recurrence is a risk.
引用
收藏
页码:441 / 452
页数:12
相关论文
共 55 条
[1]   Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation [J].
Alexander, Jacob ;
Lord, James D. ;
Yeh, Matthew M. ;
Cuevas, Carlos ;
Bakthavatsalam, Ramasamy ;
Kowdley, Kris V. .
LIVER TRANSPLANTATION, 2008, 14 (02) :245-251
[2]   Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial [J].
Angulo, P ;
Dickson, ER ;
Therneau, TM ;
Jorgensen, RA ;
Smith, C ;
DeSotel, CK ;
Lange, SM ;
Anderson, ML ;
Mahoney, DW ;
Lindor, KD .
JOURNAL OF HEPATOLOGY, 1999, 30 (05) :830-835
[3]   EASL Clinical Practice Guidelines: Management of cholestatic liver diseases [J].
Beuers, Ulrich ;
Boberg, Kirsten M. ;
Chapman, Roger W. ;
Chazouilleres, Olivier ;
Invernizzi, Pietro ;
Jones, David E. J. ;
Lammert, Frank ;
Pares, Albert ;
Trauner, Michael .
JOURNAL OF HEPATOLOGY, 2009, 51 (02) :237-267
[4]   Management of Pruritus in Chronic Liver Disease [J].
Bhalerao, Angeline ;
Mannu, Gurdeep S. .
DERMATOLOGY RESEARCH AND PRACTICE, 2015, 2015
[5]   Drug-Induced Cholestasis [J].
Bhamidimarri, Kalyan Ram ;
Schiff, Eugene .
CLINICS IN LIVER DISEASE, 2013, 17 (04) :519-+
[6]   The natural history of small-duct primary sclerosing cholangitis [J].
Bjornsson, Einar ;
Olsson, Rolf ;
Bergquist, Annika ;
Lindgren, Stefan ;
Braden, Barbara ;
Chapman, Roger W. ;
Boberg, Kirsten M. ;
Angulo, Paul .
GASTROENTEROLOGY, 2008, 134 (04) :975-980
[7]   Liver transplantation for primary sclerosing cholangitis in the Nordic countries:: Outcome after acceptance to the waiting list [J].
Brandsater, B ;
Broomé, U ;
Isoniemi, H ;
Friman, S ;
Hansen, B ;
Schrumpf, E ;
Oksanen, A ;
Ericzon, BG ;
Höckerstedt, K ;
Mäkisalo, H ;
Olsson, R ;
Olausson, M ;
Kirkegaard, P ;
Bjoro, K .
LIVER TRANSPLANTATION, 2003, 9 (09) :961-969
[8]   Primary biliary cirrhosis [J].
Carey, Elizabeth J. ;
Ali, Ahmad H. ;
Lindor, Keith D. .
LANCET, 2015, 386 (10003) :1565-1575
[9]   Diagnosis and Management of Primary Sclerosing Cholangitis [J].
Chapman, Roger ;
Fevery, Johan ;
Kalloo, Anthony ;
Nagorney, David M. ;
Boberg, Kirsten Muri ;
Shneider, Benjamin ;
Gores, Gregory J. .
HEPATOLOGY, 2010, 51 (02) :660-678
[10]   SERUM AUTOANTIBODIES, ULCERATIVE-COLITIS AND PRIMARY SCLEROSING CHOLANGITIS [J].
CHAPMAN, RW ;
COTTONE, M ;
SELBY, WS ;
SHEPHERD, HA ;
SHERLOCK, S ;
JEWELL, DP .
GUT, 1986, 27 (01) :86-91